Home Health Cancer Drugmaker Parabilis Seeks $475 Million in US IPO
Health

Cancer Drugmaker Parabilis Seeks $475 Million in US IPO

Cancer Drugmaker Parabilis Seeks $475 Million in US IPO
Key Points

Lung cancer on the left pulmonary lobe, seen on a radial section MRI scan of the chest. (Photo by: BSIP/Universal Images Group via Getty Images) Photographer: BSIP/Universal Images Group Editorial

Lung cancer on the left pulmonary lobe, seen on a radial section MRI scan of the chest. (Photo by: BSIP/Universal Images Group via Getty Images) Photographer: BSIP/Universal Images Group Editorial
Cancer Drugmaker Parabilis (ORG) US (LOCATION) BSIP/Universal Images Group (ORG) Getty Images (ORG)
Originally published by Bloomberg Markets Read original →